Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc PMEDF


Primary Symbol: C.PMED

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Comment by badog222on Jan 14, 2021 1:21pm
158 Views
Post# 32297854

RE:RE:New Vid With Rahul

RE:RE:New Vid With Rahulchristi.....Maybe one should factor in the following that was on the interview page:    Full disclosure: PredictMedix is an Equity.Guru marketing client

That means that PMED pays Eguity.Guru to provide PMED with media exposure.   Maybe that's why Chris Parry did not press Dr.  Kushwah on the revenues (or lack of) issue.  

Also, If I heard Dr. Kushwah correctly, he said that the platform has been validated.   Why then has there been no major press release to that affect including proof of validation?   Or did I miss something?  And shouldn't there be customers beating down their doors wanting to pay for this validated product?

Chris Parry asked what is the likelyhood PMED will have a device in play within the next year?  I didn't hear a definitive answer (as usual)....just something about kickstarting a study with McGill which should take the tecnology to the next dianostic level.   How did that answer the question?

The end of the interview mentioned how Quarter 1 was when PMED will have some major developments from the business development standpoint and that all the engines will be firing.  That tells me nothing.   Could be more hype.   He was careful not to mention revenues 

Seems to me that PMED is a never ending study.  IMHO It really needs paying customers if the sp is to go up instead of down.  I didn't hear anything about paying customers.  I have a hard time investing in companies with no revenues but instead are doing never ending studies.  If PMED ever announces that they have a product that customers are willing to pay for then I may think that this is a good investment.    

Badog
<< Previous
Bullboard Posts
Next >>